Mª Teresa Tórtola Fernández I am responsible for the Mycobacteria Unit at Vall d'Hebron University Hospital, which is the WHO Supranational Reference Laboratory for tuberculosis. My main line of research is the diagnosis of tuberculosis and the detection of resistance in Mycobacterium tuberculosis complex. Other lines of research are the detection and resistance of Mycobacterium abscessus complex due to its involvement in patients with cystic fibrosis and the application of molecular techniques either for epidemiology or the detection of mycobacteria. Institutions of which they are part Microbiology Vall Hebron Institut de Recerca Doctor Microbiology Cross-departmental services LinkedIn Twitter Orcid Email Mª Teresa Tórtola Fernández LinkedIn Twitter Orcid Email Institutions of which they are part Microbiology Vall Hebron Institut de Recerca Doctor Microbiology Cross-departmental services I am responsible for the Mycobacteria Unit at Vall d'Hebron University Hospital, which is the WHO Supranational Reference Laboratory for tuberculosis. My main line of research is the diagnosis of tuberculosis and the detection of resistance in Mycobacterium tuberculosis complex. Other lines of research are the detection and resistance of Mycobacterium abscessus complex due to its involvement in patients with cystic fibrosis and the application of molecular techniques either for epidemiology or the detection of mycobacteria.
I have a degree in Medicine and Surgery from the University of Barcelona; I specialized in Microbiology and Parasitology at the Vall d'Hebron Hospital, I obtained my doctorate in Medicine and Surgery at the Autonomous University of Barcelona (UAB) and I am an associate professor in the Department of Genetics and Microbiology at the UAB since 1997 I belong to the following research groups: The Tuberculosis Network European Trials Group (TBNET), Nontuberculous Mycobacteria Network European Trials Group (NTM-NET), Pediatric TB Research Network (pTBred), TB HIV study group in EuroCoord, Barcelona Tuberculosis recurrence Working Group and Spanish Infectious Pathology Research Network (REIPI). It is important to review the Barcelona Tuberculosis Recurrence Working Group group since all the people who work in the major Hospitals in the Barcelona area are part of this group and the said group has collaborated in different works with the CDC of Atlanta (USA). I have been a Tutor of residents from 2006 to 2019. I have the certificate in Teacher Training in Higher Education FDES (UAB) and I had a favorable assessment of Lecturer in the Field of Medical and Health Sciences in 2019 from the AQU. I teach classes in university training in the Degrees of Medicine and Biomedicine and I also teach in master's degrees. I have supervised 2 doctoral theses and am currently supervising 1 doctoral thesis.
Projects Grup de Recerca en Microbiologia de Hospital Universitari Vall d'Hebron IP: Juan Jose Gonzalez Lopez Collaborators: María Nieves Larrosa Escartin, Gema Codina Grau, Virginia Rodríguez Garrido, Andres Antón Pagarolas, Juliana Esperalba Esquerra, Ariadna Rando Segura, Alba Mir Cros, Yannick Hoyos Mallecot, Joan Joseph Munné, Tomàs Pumarola Suñé, Mayli Lung Suarez, Mª Teresa Tórtola Fernández, Albert Moreno Mingorance, Maria Piñana Moro, Aroa Silgado Gimenez, Elena Sulleiro Igual, Lidia Goterris Bonet, Josep Roca Grande, Alejandra Gonzalez Sánchez, Narcís Saubí Roca, Jesus Trejo Zahinos Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: 0.01 Reference: 2021 SGR 01129 Duration: 01/01/2022 - 30/06/2025 Enfermedades infecciosas IP: Israel Molina Romero Collaborators: Maria Luisa Aznar Ruiz de Alegria, Eva Baldrich Rubio, Diana Pou Ciruelo, Begoña Treviño Maruri, Pau Bosch Nicolau, Nuria Serre Delcor, Fernando M Salvador Velez, Mª Teresa Tórtola Fernández, Adrián Sánchez Montalvá, Elena Sulleiro Igual, Ines Mercedes Oliveira Souto Funding agency: Instituto de Salud Carlos III Funding: 141000 Reference: CB21/13/00029 Duration: 01/01/2022 - 31/12/2022 Multicentre Controlled Open Randomized Clinical Trial to assess efficacy and safety of an anti-TB drug combination based on high dose Rifampicin, high dose Moxifloxacin and Linezolid for DS smear positive pulmonary TB during the first 8weeks of treatmen IP: Adrián Sánchez Montalvá Collaborators: Maria Luisa Aznar Ruiz de Alegria, Mª Teresa Tórtola Fernández Funding agency: Instituto de Salud Carlos III Funding: 187550 Reference: PI20/01378 Duration: 01/01/2021 - 30/06/2025 Incorporació Dr. Benito Almirante a la RETICS en malalties infeccioses RED ESPAÑOLA DE INVESTIGACIÓN EN PATOLOGÍAS INFECCIOSAS IP: Benito Almirante Gragera Collaborators: María Nieves Larrosa Escartin, Oscar Len Abad, Judit Serra Pladevall, Gema Codina Grau, Mª Carmen Ferrer Barberà, Andres Antón Pagarolas, Rosa María Bartolomé Comas, Nuria Fernández Hidalgo, Joan Gavaldà Santapau, Juliana Esperalba Esquerra, Ma Dolores Rodríguez Pardo, Alba Mir Cros, Laura Escola Verge, Julia Sellares Nadal, Tomàs Pumarola Suñé, Carles Pigrau Serrallach, Isabel Ruiz Camps, Mayli Lung Suarez, Mª Teresa Tórtola Fernández, Juan Jose Gonzalez Lopez, Pablo Salvador Corona Pérez-Cardona, Ibai Los Arcos Bertiz, Ester Marquez Algaba Funding agency: Instituto de Salud Carlos III Funding: 401918 Reference: RD16/0016/0003 Duration: 01/01/2017 - 31/12/2022 Pagination Current page 1 Page 2 Page 3 Page 4 Next page › Last page »
